Drug Database
AM

aminolevulinic acid (ALACIN)

✓ Approved

Shanghai Fudan-Zhangjiang · 小分子 · 小分子

什么是 aminolevulinic acid?

aminolevulinic acid 是一种小分子,由Shanghai Fudan-Zhangjiang研发。该药已获批,用于治疗相关适应症,给药途径:Topical。

药物档案

商品名ALACIN
公司Shanghai Fudan-Zhangjiang
药物类别小分子
给药途径Topical
状态Approved

治疗适应症

aminolevulinic acid 针对 4 个适应症,涉及 3 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsPapilloma viral infection✓ Approved
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Brain neoplasm malignantPhase III
Skin and subcutaneous tissue disordersAcnePhase II
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Basal cell carcinomaPreclinical

相关研究文献

PubMedEnvironmental science & technology2026-11-17

Structure-Dependent Maternal-Fetal Transfer and Fetal Hepatic Accumulation of PFOA and Hexafluoropropylene Oxide (HFPO)-Based Alternatives: Implications for Fetal Liver Metabolic Disruption.

Zhang Mengqi M, Tian Yawen Y, Pan Yitao Y, Cheng Zhiwen Z et al.

Hexafluoropropylene oxide (HFPO)-based compounds have been increasingly adopted as replacements for legacy per- and polyfluoroalkyl substances (PFAS) such as perfluorooctanoic acid (PFOA), yet evidence on developmental toxicity remains limited. This study investigated structure-dependent maternal-fetal transfer, fetal tissue distribution, and hepatic effects of PFOA and four HFPO-based alternatives, including hexafluoropropylene oxide dimer acid (HFPO-DA) and hexafluoropropylene oxide trimer acid (HFPO-TA) homologues, in gestational mice. All compounds were detected in maternal serum, fetal tissues, and amniotic fluid in a dose-dependent manner, but transplacental transfer efficiencies varied markedly. C9 HFPO-TA showed the greatest fetal accumulation, indicating enhanced fetal retention. Desorption electrospray ionization mass spectrometry imaging revealed preferential hepatic localization of PFOA and HFPO trimers, with fetal hepatic burden increasing with van der Waals volume, suggesting structure-dependent enrichment. Metabolomics showed broad alterations of fetal hepatic metabolism, dominated by altered lipids and lipid-like molecules. 5-Aminolevulinic acid, a key heme precursor, was consistently reduced, whereas ALAS1 and ALAD protein levels increased, indicating perturbation of heme biosynthesis. The provisional, study-specific developmental reference doses derived from fetal or placental endpoints were comparable to or lower than those based on maternal hepatomegaly, suggesting greater developmental sensitivity. These findings reveal structure-dependent fetal liver accumulation and support incorporating fetal-specific endpoints into PFAS risk assessment.

PMID 43043284
阅读全文 →
PubMedOrphanet journal of rare diseases2026-11-17

Unmasking clinical heterogeneity and diagnostic conundrums of acute intermittent porphyria: a case series from the middle east.

Ottu Para Niyas Khalid NK, Gul Seemab S, Nagarajan Divyashri Ramanathan DR, Jacob Daya Mani DM

Acute intermittent porphyria (AIP) is a rare inherited metabolic disorder caused by an alteration in the heme synthesis pathway leading to the accumulation of porphyrins and their precursors, δ-aminolevulinic acid (ALA) and porphobilinogen (PBG). Although most patients are asymptomatic, AIP is typically characterized by a triad of abdominal pain, neurologic impairment, and psychiatric abnormalities; experienced by only a small percentage of symptomatic patients. The disease onset is usually reported to occur between the ages of 20 and 40. Due to its heterogeneity, the diagnosis of AIP is challenging and ruling out other diseases solely based on clinical assessment is difficult. This case series presents three cases of AIP with diverse clinical presentations encountered in Emirati patients at Burjeel Hospital in Abu Dhabi. This case series highlights the diagnostic difficulties and the impact of novel therapeutic strategies such as givosiran in improving patient outcomes.

PMID 43040358
阅读全文 →
PubMedThe Plant journal : for cell and molecular biology2026-11-17

A pathogen-free citrus model recapitulates Huanglongbing-associated molecular and physiological reprogramming.

Killiny Nabil N, Nehela Yasser Y, Mahoud Lamiaa M LM, Shilts Turksen T et al.

Huanglongbing (HLB) is a devastating citrus disease associated with "Candidatus Liberibacter asiaticus", but the contribution of host-driven processes to disease development remains poorly understood. Here, we developed a pathogen-free system to determine whether chloroplast dysfunction can reproduce key molecular and physiological features of HLB. Using Citrus tristeza virus-mediated silencing of phytoene desaturase (PDS) and δ-aminolevulinic acid dehydratase (ALAD), we simultaneously disrupted carotenoid and chlorophyll biosynthesis in Citrus macrophylla. Chloroplast dysfunction induced foliar chlorosis resembling that observed in HLB-affected citrus and recapitulated major alterations in pigments, stomatal behavior, primary metabolism, hormone signaling, defense responses, and starch accumulation. Transcriptomic and metabolomic analyses revealed substantial overlap between chloroplast-disrupted and "Ca. L. asiaticus"-infected plants. The two conditions shared 1067 differentially expressed genes, with extensive overlap in carbohydrate, amino acid, phenylpropanoid, flavonoid, hormone signaling, and defense pathways. Metabolomic profiles similarly converged, including sucrose depletion, hexose and amino acid accumulation, and extensive remodeling of central carbon metabolism. These findings demonstrate that chloroplast dysfunction can recapitulate a substantial component of the systemic molecular and metabolic phenotype associated with HLB. We hypothesize that chloroplast impairment during HLB contributes to metabolic, hormonal, redox, and defense reprogramming throughout the plant through chloroplast-derived signals, with potential consequences for disease progression. This pathogen-free framework identifies chloroplast stability and chloroplast-to-nucleus signaling as potential targets for further investigation in HLB pathogenesis.

PMID 43041515
阅读全文 →
PubMedClinical and molecular hepatology2026-11-17

Integrated metabolomics reveals nervonic acid-associated immunometabolic.

Xu Yunfeng Y, Xu Da D, Zhou Lina L, Zhang Ze Z et al.

Hepatocellular carcinoma (HCC) exhibits profound metabolic heterogeneity, yet the functional lipid metabolites driving tumor progression and immune microenvironment remodeling remain insufficiently defined. This study aimed to construct a metabolomic atlas of HCC and identify clinically relevant metabolic vulnerabilities. Untargeted metabolomic profiling was performed in 91 paired HCC and adjacent non-tumor tissues. Integrated metabolomic, transcriptomic, clinicopathological, and immune analyses characterized metabolic heterogeneity. Nervonic acid was evaluated in HCC cells, immunocompetent and immunodeficient mouse models, and knockdown and rescue experiments targeting ATP citrate lyase (ACLY). HCC showed extensive metabolic remodeling with limited metabolite-gene concordance. Clustering identified four metabolomic subtypes. The high-risk subtype MS1 exhibited poor prognosis, pronounced very-long-chain fatty acid remodeling, and immunosuppressive features. Nervonic acid, a very-long-chain monounsaturated fatty acid, was enriched in MS1, increased in HCC tissues, and associated with unfavorable survival. It promoted HCC cell proliferation, migration, invasion, and tumor growth. In immunocompetent models, nervonic acid reduced CD8+ T-cell infiltration and increased M2-like macrophage enrichment. Exploratory CD8 depletion suggested attenuation of the nervonic acid-associated tumor growth increment. Coordinated lipid remodeling included altered free fatty acid composition, enhanced fatty acid uptake, increased cholesterol abundance, and changes in membrane lipid order. Nervonic acid induced an ACLY-centered lipogenic program; in HCC cells, ACLY knockdown attenuated malignant phenotypes and lipid accumulation, and ACLY rescue restored these responses. Nervonic acid marks an aggressive HCC subtype with distinct immune features. Knockdown and rescue in HCC cells implicate ACLY in lipid remodeling. The prognostic value of tumor nervonic acid requires independent validation.

PMID 43041060
阅读全文 →
PubMedJournal of pediatric gastroenterology and nutrition2026-11-17

Ileal bile acid transporter inhibitors.

Di Buduo Ersilia E, Crudele Lucilla L, Cantatore Salvatore S, Moschetta Antonio A

Pediatric cholestatic liver diseases, such as Alagille syndrome and progressive familial intrahepatic cholestasis, are rare genetic disorders characterized by impaired bile flow, systemic bile acid accumulation, and debilitating pruritus. Historically managed with supportive care or invasive surgical interventions, the therapeutic landscape has recently expanded with the introduction of ileal bile acid transporter (IBAT) inhibitors. These luminal, ileum-targeted agents block bile acid reabsorption, thereby increasing fecal bile acid excretion and effectively reducing the systemic bile acid pool to relieve pruritus. However, this pharmacological blockade also attenuates the intestinal farnesoid X receptor (FXR)-fibroblast growth factor 19 (FGF19) feedback loop, leading to a compensatory increase in hepatic bile acid synthesis. Consequently, the clinical efficacy and safety of IBAT inhibitors are heavily dependent on a sufficiently preserved enterohepatic bile flow and canalicular export capacity. When luminal bile acid delivery is impaired, therapeutic benefits diminish, and the unchecked compensatory synthesis may contribute to hepatocyte stress and elevated transaminases. Thus, optimizing the use of these therapies will require a shift from broad disease-label indications toward precision, genotype- and physiology-informed patient selection, utilizing non-invasive biomarkers to assess target engagement and guide clinical management.

PMID 43042691
阅读全文 →
PubMedClinical hemorheology and microcirculation2026-11-17

Uric acid/HDL-cholesterol ratio and uric acid/mean erythrocyte aggregation ratio in subclinical carotid atherosclerosis.

Caimi Gregorio G, Lo Presti Rosalia R, Urso Caterina C, Brucculeri Salvatore S et al.

Background and aimSeveral literature studies have highlighted an association between elevated serum acid levels and cardiovascular diseases, including atherosclerotic disease, with also a link in case of normal uricemia values; in relation to this relation, in this new study regarding our cohort of subjects with subclinical carotid atherosclerosis, we have examined the uric acid/HDL-C ratio and the uric acid/mean erythrocyte aggregation ratio.MethodsOur retrospective, cross-sectional, and explorative study population includes 100 subjects (43 men and 57 women) with subclinical carotid atherosclerosis; in this population we have evaluated: serum uric acid, HDL-Cholesterol, mean erythrocyte aggregation, uric acid/HDL-C ratio (UHR) and uric acid/mean erythrocyte aggregation ratio (UEAR).ResultsFrom the obtained data we observed that only UHR is able to discriminate the subgroups of the whole cohort assembled according to the number of cardiovascular risk factors and according to the degree of insulin resistance evaluated with some surrogate indices; moreover, the UHR is positively correlated with each index of insulin resistance.ConclusionThese data confirm the possible utility of UHR, and at the same time, despite the premises, the UEAR does not seam to have, at now, any particular role in this clinical condition.

PMID 43042619
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多aminolevulinic acid